Search

Your search keyword '"Carcinoma -- Care and treatment"' showing total 1,169 results

Search Constraints

Start Over You searched for: Descriptor "Carcinoma -- Care and treatment" Remove constraint Descriptor: "Carcinoma -- Care and treatment"
1,169 results on '"Carcinoma -- Care and treatment"'

Search Results

1051. Diagnosis and treatment of thyroid carcinoma reviewed

1052. Platinum-based chemotherapy is efficacious in uterine papillary serous carcinoma

1053. Platinum-based chemotherapy is efficacious in uterine papillary serous carcinoma

1054. Platinum-based chemotherapy is efficacious in uterine papillary serous carcinoma

1055. Cases of small cell carcinoma of the esophagus analyzed

1056. Surgical treatment of salivary duct carcinoma of submandibular gland reviewed

1057. Surgical treatment of salivary duct carcinoma of submandibular gland reviewed

1058. Surgical treatment of salivary duct carcinoma of submandibular gland reviewed

1059. Combined therapies affected quality of life in nasopharyngeal carcinoma patients

1060. Combined therapies affected quality of life in nasopharyngeal carcinoma patients

1061. Combined therapies affected quality of life in nasopharyngeal carcinoma patients

1062. Use of chemoradiotherapy to treat esophageal carcinoma investigated

1063. Adjuvant systemic therapy used to treat male breast carcinoma

1064. Methods for enumerating circulating tumor cells in carcinoma patients compared

1065. Surgeon perspectives about local therapy for breast carcinoma shared

1066. Surgeon perspectives about local therapy for breast carcinoma shared

1067. Distribution of positive lymph nodes in patients with N0 oropharyngeal carcinoma assessed

1068. Surgeon perspectives about local therapy for breast carcinoma shared

1069. Gemcitabine and irinotecan treated patients with carcinoma of an unknown primary site

1070. Gemcitabine and irinotecan treated patients with carcinoma of an unknown primary site

1071. Gemcitabine and irinotecan treated patients with carcinoma of an unknown primary site

1072. Pharmacokinetics of S-1 plus cisplatin studied in patients with advanced gastric carcinoma

1073. Chemoradiotherapy improved tumor control of nasopharyngeal carcinoma

1074. Papillary thyroid carcinoma after recombinant GH therapy for Turner syndrome

1075. Pharmacokinetics of S-1 plus cisplatin studied in patients with advanced gastric carcinoma

1076. Chemoradiotherapy improved tumor control of nasopharyngeal carcinoma

1077. Papillary thyroid carcinoma after recombinant GH therapy for Turner syndrome

1078. Pharmacokinetics of S-1 plus cisplatin studied in patients with advanced gastric carcinoma

1079. Chemoradiotherapy improved tumor control of nasopharyngeal carcinoma

1080. Papillary thyroid carcinoma after recombinant GH therapy for Turner syndrome

1081. Adjuvant therapy with chemotherapy increases survival of women with serous carcinoma

1082. Adjuvant therapy with chemotherapy increases survival of women with serous carcinoma

1083. Adjuvant therapy with chemotherapy increases survival of women with serous carcinoma

1084. Exclusive low-dose-rate brachytherapy used to treat T2N0 mobile tongue carcinoma

1085. CT and FDG-PET image fusion impacted treatment planning and management of esophageal carcinoma

1086. Paclitaxel was well tolerated but showed limited efficacy in bronchioloalveolar carcinoma

1087. Exclusive low-dose-rate brachytherapy used to treat T2N0 mobile tongue carcinoma

1088. CT and FDG-PET image fusion impacted treatment planning and management of esophageal carcinoma

1089. Paclitaxel was well tolerated but showed limited efficacy in bronchioloalveolar carcinoma

1090. Exclusive low-dose-rate brachytherapy used to treat T2N0 mobile tongue carcinoma

1091. CT and FDG-PET image fusion impacted treatment planning and management of esophageal carcinoma

1092. Paclitaxel was well tolerated but showed limited efficacy in bronchioloalveolar carcinoma

1093. Low-dose GM-CSF used as salvage therapy in breast and genital tract carcinoma

1094. Brachytherapy is replacing other treatment modalities for prostate carcinoma

1095. Low-dose GM-CSF used as salvage therapy in breast and genital tract carcinoma

1096. Brachytherapy is replacing other treatment modalities for prostate carcinoma

1097. Low-dose GM-CSF used as salvage therapy in breast and genital tract carcinoma

1098. Brachytherapy is replacing other treatment modalities for prostate carcinoma

1099. EAU guidelines on diagnosis and treatment of urothelial carcinoma revealed

1100. Thyroid resection with radioactive iodine ablation can be used to treat papillary thyroid carcinoma

Catalog

Books, media, physical & digital resources